跳至主要内容
临床试验/NCT01994863
NCT01994863终止2 期

An Open-labeled, Randomised, Controlled, Comparative, Cross-over Study Investigating the Safety and Performance of a New 1-piece Ostomy Product Compared to Standard Care 1-piece in Subjects With Ileostomy

Coloplast A/S1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2012年9月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
终止
发起方
Coloplast A/S
入组人数
23
试验地点
1
主要终点
Leakage

研究概览

简要总结

The objective of the investigation is to document New Mio 1-piece is non-inferior (no worse) in reducing leakage (4-point scale) compared to Standard of Care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Have given written informed consent
  • •Be at least 18 years of age and have full legal capacity
  • •Be able to handle the appliance themselves or with help from caregiver (e.g. spouse)
  • •Have an ileostomy with a diameter between 15 and 45 mm
  • •Have had their ostomy for at least three months
  • •Currently use a 1-piece flat product with open bag
  • •Use minimum 1 product every second day.
  • •Be suitable for participation in the investigation and for using a standard adhesive, flat base plate
  • •Must use custom cut product
  • •Accept to test two 1-piece products within the study

排除标准

  • •Use irrigation during the study (flush the stoma with water)
  • •Currently receiving or have within the past 2 months received radio- and/or chemotherapy
  • •Currently receiving or have within the past month received systemic steroid or local treatment in the peristomal area
  • •Are pregnant or breastfeeding
  • •Participating in other interventional clinical investigations or have previously participated in this investigation
  • •Has more than three days wear time

研究组 & 干预措施

First Coloplast Test product; then Standard Care (see below)

Experimental

The subjects are randomised to test Coloplast Test product first and thereafter test Standard Care.

Standard Care is a collection of three different already marketed 1-piece flat ostomy appliances. These are Coloplast Sensura 1-piece; Hollister: Moderma 1-piece and B.Braun Flexima 1-piece.

The three Standard Care products were tested in a 1:1:1 randomisation.

干预措施: Coloplast Test product (Device)

First Coloplast Test product; then Standard Care (see below)

Experimental

The subjects are randomised to test Coloplast Test product first and thereafter test Standard Care.

Standard Care is a collection of three different already marketed 1-piece flat ostomy appliances. These are Coloplast Sensura 1-piece; Hollister: Moderma 1-piece and B.Braun Flexima 1-piece.

The three Standard Care products were tested in a 1:1:1 randomisation.

干预措施: Standard Care (Device)

First Standard Care (see below); Then coloplast test product

Experimental

The subjects are randomised to test Standard care first and thereafter test Coloplast test product.

Standard Care is a collection of three different already marketed 1-piece flat ostomy appliances. These are Coloplast Sensura 1-piece; Hollister: Moderma 1-piece and B.Braun Flexima 1-piece.

The three Standard Care products were tested in a 1:1:1 randomisation.

干预措施: Coloplast Test product (Device)

First Standard Care (see below); Then coloplast test product

Experimental

The subjects are randomised to test Standard care first and thereafter test Coloplast test product.

Standard Care is a collection of three different already marketed 1-piece flat ostomy appliances. These are Coloplast Sensura 1-piece; Hollister: Moderma 1-piece and B.Braun Flexima 1-piece.

The three Standard Care products were tested in a 1:1:1 randomisation.

干预措施: Standard Care (Device)

结局指标

主要结局

Leakage

时间窗: 14+/-3 days per product

The percentage of baseplates with no leakage/seeping under the baseplate was measured. Leakage/seeping under the baseplate was assessed after each baseplate change.

次要结局

未报告次要终点

研究者

发起方
Coloplast A/S
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

尚未招募
3 期
ESPRIT TOXIL-2 UNSW PSO 6361rlL-2 toxicityInterleukin-2 therapyHIVInfection - Acquired immune deficiency syndrome (AIDS / HIV)
ACTRN12605000407695niversity of New South Wales, Sydney, Australia.168
进行中(未招募)
1 期
Randomized study in patients with chronic HIV infection.HIV chronic infectionMedDRA version: 17.0Level: LLTClassification code 10001509Term: AIDSSystem Organ Class: 100000004862
EUCTR2014-000515-14-ESFundación SEIMC-GESIDA
进行中(未招募)
不适用
Randomized, Open label, Non-inferiority Study of Micafungin versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients - TENPIN (Liver Transplant EuropeaN study into the Prevention of fungal InfectioN)MedDRA version: 14.1Level: LLTClassification code 10042941Term: Systemic fungal infection NOSSystem Organ Class: 100000004862Fungal infection.
EUCTR2008-005214-49-PTAstellas Pharma Europe Ltd338
进行中(未招募)
不适用
Randomized, Open label, Non-inferiority Study of Micafungin versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients - TENPIN (Liver Transplant EuropeaN study into the Prevention of fungal InfectioN)Fungal infection.MedDRA version: 9.1Level: LLTClassification code 10042941Term: Systemic fungal infection NOS
EUCTR2008-005214-49-SEAstellas Pharma Europe Ltd338
进行中(未招募)
1 期
Randomized, Open label, Non-inferiority Study of Micafungin versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients - TENPIN (Liver Transplant EuropeaN study into the Prevention of fungal InfectioN)Fungal infection.MedDRA version: 9.1Level: LLTClassification code 10042941Term: Systemic fungal infection NOS
EUCTR2008-005214-49-CZAstellas Pharma Europe Ltd338